Dermal fillers are a common treatment for cosmetic service patients. Because they can be used in so many cases—for patients who want plumper lips, enhanced facial contours, softened creases and wrinkles, and so on—new dermal fillers are always being researched. In the United States, fewer of these treatments are available since the approval process is stricter than in most other countries; thus, when a new dermal filler is FDA approved, it’s time to take notice. Today, that means taking a look at Revanesse Versa.
Revanesse Versa, and Why You Should Offer It
Revanesse Versa is a hyaluronic acid dermal filler that has been used for several years in Canada and Europe without issue before being launched in the U.S. in January 2018. Before we even discuss what it does, we have the first reason why it’s a fine product for your patients—this is not a new, semi-experimental treatment. It has years of use to draw on as proof of its safety and effectiveness.
As a dermal filler, hyaluronic acid is uniquely powerful. When injected, it has the power to penetrate deeply into the skin, ensuring all changes are not merely superficial, and it can hold one thousand times its weight in water. This means very little hyaluronic acid is needed to plump and hydrate skin and lips; in turn, injections are small, causing minimal pain and no downtime for the patient.
In addition, the hyaluronic acid itself is of superior quality. It has a high molecular weight, which studies from the National Institutes of Health
Swelling is minimized with Revanesse Versa. This is mainly contributed to painstaking quality standards employed in the manufacturing process to ensure the final product has minimal hydrophilic properties. The smaller injections mean that Revanesse Versa patients deal with almost twenty-five percent less swelling than with other dermal fillers. For patients interested in a “lunchtime facelift”, who need to get back to work immediately afterward, the lack of noticeable swelling is a major bonus.
All in all, Revanesse Versa treatments offer outstanding, natural-looking results. The first time one of your patients is complimented on their appearance without asking if they had work done, they’ll know Revanesse Versa is the right treatment for them.
Limitations of Revanesse Versa
Although Revanesse Versa is an excellent product to offer, it won’t be the correct treatment for every patient.
- It can be used for such purposes as increasing lip volume, but it is designed to improve the appearance of facial wrinkles and creases, such as nasolabial folds. It is intended for individuals twenty-two years of age and up, and should not be offered to any younger patients.
- Do not offer Revanesse Versa to pregnant or breastfeeding women, as the safety of the product for use by pregnant or breastfeeding women has not been studied.
- Patients with a history of hypertrophic scarring, keloid formation, or with evidence of scars at the intended treatment sites should not use Revanesse Versa.
- Patients with an acute or chronic skin disease (ie. seborrheic dermatitis or rosacea) in or near the injection sites, or any infection or unhealed wound of the face, should not use Revanesse Versa.
- Revanesse Versa should not be used to treat patients under concomitant anticoagulant therapy, antiplatelet therapy, or who have a history of bleeding or clotting disorders.
For most clinics, these limitations will only affect a small percentage of their patient base.
If you agree that Revanesse Versa would be a good product to add to your practice,